Prospective Clinical Database Construction for Liver Canc... | NCT07587216

Studies
Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment

NCT07587216

Sponsor

Tongji Hospital

Status

Recruiting

Last Update Posted

Jun 4, 2026Actual

Enrollment

800Estimated

Phase

Not provided

Conditions

Liver Cancer (Primary and Metastatic)

Interventions

liver resection
Systemic therapy combined with locoregional interventions

Countries

China

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

May 2026

Overall Recruitment Status or Expanded Access Status

Recruiting

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jan 1, 2026Actual

Primary Completion Date

Dec 31, 2027Estimated

Completion Date

Dec 31, 2029Estimated

First Submitted Date

May 8, 2026

First Submission Date that Met QC Criteria

May 8, 2026

First Posted Date

May 14, 2026Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jun 2, 2026

Last Update Posted Date

Jun 4, 2026Actual

Sponsor/Collaborators Module

Responsible Party, by Official Title

Cheng Qi, Deputy Director of Hepatobiliary and Pancreatic Surgery Department, Tongji HospitalPrincipal Investigator

Lead Sponsor

Tongji HospitalOTHER

Collaborators

Not provided

Oversight Module

Has Data Monitoring Committee (DMC)

Yes

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

This study is a prospective, observational, real-world cohort study. We aim to establish a prospective database in the Department of Hepatobiliary and Pancreatic Surgery, systematically collecting and integrating patients' full-course diagnostic and therapeutic information along with long-term outcomes. This will enable objective evaluation of prognosis and treatment efficacy in real-world clinical practice, while providing a data foundation and evidence support for subsequent optimization of clinical decision-makin

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Yes

Target Follow-Up Duration

2 Years

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

800Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Liver resection group			Procedure: liver resection
Non-surgery group			Drug: Systemic therapy combined with locoregional interventions

Interventions

Name	Type	Description	Arm Group Labels	Other Names
liver resection	Procedure	Patients undergo liver resection for tumor.	Liver resection group

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
overall survival		From date of treatment until the date of death from any cause, assessed up to 100 months

Secondary Outcomes

Measure	Description	Time Frame
Incidence of Adverse Events		Within 30 days following interventions

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Male or female aged ≥18 years at the time of signing the informed consent form
Clinically or histologically confirmed diagnosis of liver cancer
Recieving treatment and follow-up in Tongji Hospital

Exclusion Criteria:

- Refuse participanting in this study

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

patients with liver cancer

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Qi Cheng, M.D.	Contact	13871459541		chengqi@hust.edu.cn

Overall Officials

Not provided

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology	Recruiting	Wuhan	Hubei	430030	China

Condition Browse Module

MeSH Terms

ID	Term
D008113	Liver Neoplasms
D009362	Neoplasm Metastasis

Ancestor Terms

ID	Term
D004067	Digestive System Neoplasms
D009371	Neoplasms by Site
D009369	Neoplasms
D004066	Digestive System Diseases

Browse Leaves

Not provided

Browse Branches

Not provided

Intervention Browse Module

MeSH Terms

ID	Term
D006498	Hepatectomy

Ancestor Terms

ID	Term
D013505	Digestive System Surgical Procedures
D013514	Surgical Procedures, Operative

Browse Leaves

Not provided

Browse Branches

Not provided